UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.724

Sortiert nach

PG 10.02 Predicting the response to neoadjuvant chemotherapy II (Ability of pretherapeutic parameters to predict response and prognosis early in patients with locally advanced gastric cancer)

European journal of cancer (1990), 2012-03, Vol.48, p.S10-S10

Lorenzen, S

2012

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

Annals of oncology, 2009-10, Vol.20 (10), p.1667-1673

2009

Link zum Volltext

Verfügbarkeit prüfen

The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)

BMC cancer, 2017-02, Vol.17 (1), p.130-130, Article 130

2017

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab plus oxaliplatin leucovorin 5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

British journal of cancer, 2010-02, Vol.102 (3), p.500-505

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparative Study on Ion-Dynamics for Broadening of Lyman Lines in Dense Hydrogen Plasmas

Contributions to plasma physics (1988), 2013-05, Vol.53 (4-5), p.368-374

Lorenzen, S.

2013

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer

British journal of cancer, 2013-02, Vol.108 (3), p.519-526

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy

Annals of oncology, 2013-08, Vol.24 (8), p.2068-2073

2013

Link zum Volltext

Verfügbarkeit prüfen

EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity

Annals of oncology, 2018-04, Vol.29 (4), p.1010-1015

2018

Link zum Volltext

Verfügbarkeit prüfen

Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (17), p.16231-16238

2023

Link zum Volltext

Verfügbarkeit prüfen

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Annals of oncology, 2007-10, Vol.18 (10), p.1673-1679

2007

Link zum Volltext

Verfügbarkeit prüfen

Early clinical trial unit tumor board: a real-world experience in a national cancer network

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (14), p.13383-13390

2023

Link zum Volltext

Verfügbarkeit prüfen

Extended-spectrum β-lactamase–producing Enterobacteriaceae among geckos (Hemidactylus brookii) in a Ghanaian hospital

Clinical microbiology and infection, 2019-08, Vol.25 (8), p.1048-1050

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeting of the tail-anchored peroxisomal membrane proteins PEX26 and PEX15 occurs through C-terminal PEX19-binding sites

Journal of cell science, 2006-06, Vol.119 (12), p.2508-2517

2006

Link zum Volltext

Verfügbarkeit prüfen

Tolerable Duration of Warm Ischaemia After Circulatory Death Is Safe For At Least One Hour in Porcine Lungs: Functional Assessment with Ex Vivo Lung Perfusion

The Heart surgery forum, 2022-01, Vol.25 (1), p.E048-E052

2022

Link zum Volltext

Verfügbarkeit prüfen

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma

ESMO open, 2022-12, Vol.7 (6), p.100613-100613, Article 100613

2022

Link zum Volltext

Verfügbarkeit prüfen

The Short-term Predictive Value of Vessel Wall Stiffness on Abdominal Aortic Aneurysm Growth

Annals of vascular surgery, 2021-11, Vol.77, p.187-194

2021

Link zum Volltext

Verfügbarkeit prüfen

On PAC-Bayesian bounds for random forests

Machine learning, 2019-09, Vol.108 (8-9), p.1503-1522

2019

Link zum Volltext

Verfügbarkeit prüfen

Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): The randomized phase II INTEGA trial (AIO STO 0217)

Annals of oncology, 2018-10, Vol.29, p.viii265-viii266

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of pulsed-vacuum and ohmic heating on the osmodehydration kinetics, physical properties and microstructure of apples (cv. Granny Smith)

Innovative food science & emerging technologies, 2011-10, Vol.12 (4), p.562-568

2011

Link zum Volltext

Verfügbarkeit prüfen

Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

Annals of oncology, 2018-12, Vol.29 (12), p.2393-2395

2018

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin/5-fluorouracil +/- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker program

Annals of oncology, 2018-06, Vol.29, p.v103-v103

2018

Link zum Volltext

Verfügbarkeit prüfen

Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in mice

Behavioural brain research, 2016-04, Vol.303, p.34-43

2016

Link zum Volltext

Verfügbarkeit prüfen

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

ESMO open, 2021-08, Vol.6 (4), p.100200, Article 100200

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.724

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.710)
Mit Volltextzugriff
(4.171)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.188)
Life Sciences & Biomedicine
(1.733)
Humans
(902)
Male
(530)
Biological And Medical Sciences
(522)
Animals
(517)
Female
(493)
Adult
(318)
Middle Aged
(317)
Physical Sciences
(317)
Fundamental And Applied Biological Sciences. Psychology
(311)
Technology
(261)
Aged
(250)
Environmental Sciences & Ecology
(235)
Medical Sciences
(230)
Ecology
(210)
Oncology
(172)
Social Sciences
(148)
Engineering
(140)
Biochemistry & Molecular Biology
(138)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(34)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

PG 10.02 Predicting the response to neoadjuvant chemotherapy II (Ability of pretherapeutic parameters to predict response and prognosis early in patients with locally advanced gastric cancer)

Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Cetuximab plus oxaliplatin leucovorin 5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Comparative Study on Ion-Dynamics for Broadening of Lyman Lines in Dense Hydrogen Plasmas

Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer

Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy

EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity

Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Early clinical trial unit tumor board: a real-world experience in a national cancer network

Extended-spectrum β-lactamase–producing Enterobacteriaceae among geckos (Hemidactylus brookii) in a Ghanaian hospital

Targeting of the tail-anchored peroxisomal membrane proteins PEX26 and PEX15 occurs through C-terminal PEX19-binding sites

Tolerable Duration of Warm Ischaemia After Circulatory Death Is Safe For At Least One Hour in Porcine Lungs: Functional Assessment with Ex Vivo Lung Perfusion

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma

The Short-term Predictive Value of Vessel Wall Stiffness on Abdominal Aortic Aneurysm Growth

On PAC-Bayesian bounds for random forests

Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): The randomized phase II INTEGA trial (AIO STO 0217)

Effect of pulsed-vacuum and ohmic heating on the osmodehydration kinetics, physical properties and microstructure of apples (cv. Granny Smith)

Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

Quality-of-life (QoL) results from RAINFALL: A randomized, double-blind, placebo (PL)-controlled phase III study of cisplatin (Cis) plus capecitabine (Cape) or 5FU with or without ramucirumab (RAM) as first-line therapy for metastatic gastric or gastroesophageal junction (G-GEJ) cancer

Cisplatin/5-fluorouracil +/- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker program

Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in mice

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

Suchergebnisse filtern